Evidence map›Paper›PMID 32517147›Full record

ArticleMicroorganisms2020

Spill-Over from Public Health? First Detection of an OXA-48-Producing

Alexandra Irrgang, Natalie Pauly, Bernd-Alois Tenhagen, Mirjam Grobbel, Annemarie Kaesbohrer, And Jens A Hammerl

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Genotypic Characterization of UropathogenicAntibiotics (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. [Therapy-relevant antibiotic resistances in a One Health context].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2023
    Review
  7. Article
  8. Article
  9. Epidemiology and zoonotic transmission ofFrontiers in microbiology · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The hazard of carbapenemase (OXA-181)-producingFrontiers in microbiology · 2022
    Article
  15. Dissection of Highly PrevalentAntibiotics (Basel, Switzerland) · 2021
    Article
  16. Characterization ofMicroorganisms · 2021
    Article
  17. Multiresistant Gram-Negative Pathogens—A Zoonotic Problem.Deutsches Arzteblatt international · 2021
    Review
  18. Article
  19. Phylogenetically DiverseBioMed research international · 2021
    Article
  20. Identification of aMicroorganisms · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Alexandra IrrgangGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), Department Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, D-10589 Berlin, Germany.
Natalie PaulyGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), Department Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, D-10589 Berlin, Germany.
Bernd-Alois TenhagenGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), Department Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, D-10589 Berlin, Germany.
Mirjam GrobbelGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), Department Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, D-10589 Berlin, Germany.
Annemarie KaesbohrerGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), Department Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, D-10589 Berlin, Germany.
And Jens A HammerlGerman Federal Institute for Risk Assessment (Bundesinstitut für Risikobewertung, BfR), Department Biological Safety, Unit Epidemiology, Zoonoses and Antimicrobial Resistance, D-10589 Berlin, Germany.
Federal Institute for Risk Assessment · DEUniversity of Veterinary Medicine Vienna · AT

Funding

Bundesinstitut für Risikobewertung 43-001Bundesinstitut für Risikobewertung 43-002One Health European Joint Programme 773830
6 · The paper itself

Abstract

Resistance to carbapenems is a severe threat to human health. These last resort antimicrobials are indispensable for the treatment of severe human infections with multidrug-resistant Gram-negative bacteria. In accordance with their increasing medical impact, carbapenemase-producing Enterobacteriaceae (CPE) might be disseminated from colonized humans to non-human reservoirs (i.e., environment, animals, food). In Germany, the occurrence of CPE in livestock and food has been systematically monitored since 2016. In the 2019 monitoring, an OXA-48-producing

Indexed as

carbapenemaseCPEfood chainOXA-48

Identifiers

PMID32517147
PMCPMC7356166
OpenAlexW3032991184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.